Book a Meeting

Anti-F3 Antibody, Non-Fucosylated (BioBet-229ZP) (CAT#: BioBet-229ZP) Datasheet

Target
F3
Isotype
IgG1, κ
Description
Anti-F3 Antibody, Non-Fucosylated (BioBet-229ZP) is a human monoclonal IgG1, κ antibody against F3. This product is an ADCC enhanced antibody produced by our Afuco™ platform.
Antibody Indication
Solid tumors
Classification
Therapeutic antibody; biobetter

Cooperation Seeking

Creative Biolabs is interested in collaborating with potential partners (include but not limit to major pharma or biotech firms) to further co-develop ADCC-enhanced F3 antibody. For commercial partners interested in our ADCC-enhanced therapeutic antibodies, Creative Biolabs welcomes collaboration. Here are two ways for your choice, and please contact us for more details.
1) Collaborate with us and co-develop the programs from discovery phase to IND enabling. Costs will be shared.
2) Become a licensed candidate of our programs.
Looking forward to cooperating with you in the near future.
Official Name
F3
Full Name
Coagulation Factor III, Tissue Factor
Background
This gene encodes coagulation factor III which is a cell surface glycoprotein. This factor enables cells to initiate the blood coagulation cascades, and it functions as the high-affinity receptor for the coagulation factor VII. The resulting complex provides a catalytic event that is responsible for initiation of the coagulation protease cascades by specific limited proteolysis. Unlike the other cofactors of these protease cascades, which circulate as nonfunctional precursors, this factor is a potent initiator that is fully functional when expressed on cell surfaces. There are 3 distinct domains of this factor: extracellular, transmembrane, and cytoplasmic. This protein is the only one in the coagulation pathway for which a congenital deficiency has not been described. Alternate splicing results in multiple transcript variants.[provided by RefSeq, May 2010]
Alternative Names
F3; coagulation factor III (thromboplastin, tissue factor); TF; TFA; CD142; tissue factor;
Gene ID
UniProt ID
Cellular Localization
Extracellular region or secreted
Involvement in Disease
Diseases associated with F3 include Disseminated Intravascular Coagulation and Carotid Artery Thrombosis.
Related Pathways
Its related pathways are Formation of Fibrin Clot (Clotting Cascade) and Response to elevated platelet cytosolic Ca2+.
Function
By forming a complex with circulating factor VII or VIIa, blood coagulation is initiated. [TF:VIIa] The complex activates factor IX or X through specific limited proteolysis. TF plays a role in normal hemostasis by initiating the cell surface assembly and proliferation of the coagulation protease cascade.
Post-translational modifications
1.Glycosylation at Asn156 and Asn169 2.Modification sites at PhosphoSitePlus
Biologic Classification
Protein Based Therapies
Monoclonal antibody (mAb)
Antibody Isotype
IgG1, κ
Antibody Clone
BioBet-229ZP
Host
Human
Species Reactivity
Human
Description
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to F3. tisotumab is a human monoclonal antibody that can be potentially used in the treatment of Solid tumors.
Antibody Indication
Solid tumors

Solid tumors

All products and services are for Research Use Only. Do Not use in humans.

ONLINE INQUIRY

Creative Biolabs has established a team of customer support scientists ready to discuss ADCC/CDC optimization strategies, antibody production, bioinformatics analysis and other molecular biology/biotechnology issues.

  • *
  • *

ISO 9001 Certified - Creative Biolabs Quality Management System.
© 2025 Creative Biolabs. All rights reserved.
Merry Christmas Merry Christmas